182 related articles for article (PubMed ID: 33983583)
1. Theranostics for Breast Cancer Stem Cells.
Moon WK; Kim HS
Adv Exp Med Biol; 2021; 1187():267-281. PubMed ID: 33983583
[TBL] [Abstract][Full Text] [Related]
2. MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
Sun Y; Kim HS; Park J; Li M; Tian L; Choi Y; Choi BI; Jon S; Moon WK
Theranostics; 2014; 4(8):845-57. PubMed ID: 24955145
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging-Guided Drug Delivery to Breast Cancer Stem-Like Cells.
Sun Y; Kim HS; Kang S; Piao YJ; Jon S; Moon WK
Adv Healthc Mater; 2018 Nov; 7(21):e1800266. PubMed ID: 30146770
[TBL] [Abstract][Full Text] [Related]
4. The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges.
Lin X; Wang Y; Fang K; Guo Z; Lin N; Li L
Stem Cell Res Ther; 2023 Dec; 14(1):356. PubMed ID: 38072976
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cells as novel biomarkers.
Ray SK; Mukherjee S
Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
7. Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.
Sun Y; Kim HS; Saw PE; Jon S; Moon WK
Adv Healthc Mater; 2015 Aug; 4(11):1675-80. PubMed ID: 26097122
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
[TBL] [Abstract][Full Text] [Related]
12. A Bright Horizon of Intelligent Targeted-cancer Therapy: Nanoparticles Against Breast Cancer Stem Cells.
Vaez A; Abbasi M; Shabani L; Azizipour E; Shafiee M; Zare MA; Rahbar O; Azari A; Amani AM; Golchin A
Curr Stem Cell Res Ther; 2023; 18(6):787-799. PubMed ID: 36200213
[TBL] [Abstract][Full Text] [Related]
13. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
Lv L; Shi Y; Wu J; Li G
Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications.
Conde I; Ribeiro AS; Paredes J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326385
[TBL] [Abstract][Full Text] [Related]
15. RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
Chen F; Gurler SB; Novo D; Selli C; Alferez DG; Eroglu S; Pavlou K; Zhang J; Sims AH; Humphreys NE; Adamson A; Campbell A; Sansom OJ; Tournier C; Clarke RB; Brennan K; Streuli CH; Ucar A
Oncogene; 2023 Feb; 42(9):679-692. PubMed ID: 36599922
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
18. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
[TBL] [Abstract][Full Text] [Related]
19. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
20. EDB Fibronectin-Specific SPECT Probe
Ye XX; Zhao YY; Wang Q; Xiao W; Zhao J; Peng YJ; Cao DH; Lin WJ; Si-Tu MY; Li MZ; Zhang X; Zhang WG; Xia YF; Yang X; Feng GK; Zeng MS
ACS Omega; 2017 Jun; 2(6):2459-2468. PubMed ID: 30023665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
